Category: Pharmaceuticals
Pharmaceuticals market research reports by GlobalData
-
Cystic Fibrosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Cystic Fibrosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Cystic Fibrosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 U ... Read More
-
Trigeminal Neuralgia (Tic Douloureux) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Trigeminal Neuralgia (Tic Douloureux) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Trigeminal Neuralgia (Tic Douloureux) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Sta ... Read More
-
Gonorrhea Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Gonorrhea Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Gonorrhea Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update provid ... Read More
-
Pulmonary Fibrosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Pulmonary Fibrosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Pulmonary Fibrosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, ... Read More
-
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Clinical Trial Analysis by Trial ... Read More
-
Lennox-Gastaut Syndrome (LGS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Lennox-Gastaut Syndrome (LGS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in LGS therapeutics. More than 89,000 total prevalent cases of LGS are anticipated in 2 ... Read More
-
Purdue Pharma LP - Strategic SWOT Analysis Review
Purdue Pharma LP - Strategic SWOT Analysis Review - provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser ... Read More
-
Ipsen Biopharmaceuticals Inc - Strategic SWOT Analysis Review
Ipsen Biopharmaceuticals Inc - Strategic SWOT Analysis Review - provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod ... Read More
-
AstraZeneca Plc - Digital Transformation Strategies
AstraZeneca Plc - Digital Transformation Strategies Summary This report provides insight into AstraZeneca's tech activities, including its digital transformation strategies, its innovation programs, its technology initiatives, its estimated ICT budget, and its major ICT contracts. AstraZeneca Plc (A ... Read More
-
Antisense Therapeutics Ltd (ANP) - Financial and Strategic SWOT Analysis Review
Antisense Therapeutics Ltd (ANP) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w ... Read More
-
Maruho Co Ltd - Strategic SWOT Analysis Review
Maruho Co Ltd - Strategic SWOT Analysis Review - provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic ... Read More
-
Emcure Pharmaceuticals Ltd - Strategic SWOT Analysis Review
Emcure Pharmaceuticals Ltd - Strategic SWOT Analysis Review - provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc ... Read More
-
Isagenix International LLC - Strategic SWOT Analysis Review
Isagenix International LLC - Strategic SWOT Analysis Review - provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc ... Read More
-
Eisai Inc - Strategic SWOT Analysis Review
Eisai Inc - Strategic SWOT Analysis Review - provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. ... Read More
-
Helix BioMedix Inc (HXBM) - Financial and Strategic SWOT Analysis Review
Helix BioMedix Inc (HXBM) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness ... Read More
-
Metachromatic Leukodystrophy (MLD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Metachromatic Leukodystrophy (MLD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in MLD therapeutics. More than 5,500 diagnosed prevalent cases of MLD are anticipa ... Read More
-
Mexico Reversible Contraceptive Procedures Count by Segments and Forecast to 2030
Mexico Reversible Contraceptive Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “Mexico Reversible Contraceptive Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Mexico Reversible Contraceptive Procedures. The databook report ... Read More
-
Russia Reversible Contraceptive Procedures Count by Segments and Forecast to 2030
Russia Reversible Contraceptive Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “Russia Reversible Contraceptive Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Russia Reversible Contraceptive Procedures. The databook report ... Read More
-
Japan Reversible Contraceptive Procedures Count by Segments and Forecast to 2030
Japan Reversible Contraceptive Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “Japan Reversible Contraceptive Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Japan Reversible Contraceptive Procedures. The databook report pro ... Read More
-
South Korea Reversible Contraceptive Procedures Count by Segments and Forecast to 2030
South Korea Reversible Contraceptive Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “South Korea Reversible Contraceptive Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the South Korea Reversible Contraceptive Procedures. The d ... Read More
-
Canada Reversible Contraceptive Procedures Count by Segments and Forecast to 2030
Canada Reversible Contraceptive Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “Canada Reversible Contraceptive Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Canada Reversible Contraceptive Procedures. The databook report ... Read More
-
Spain Reversible Contraceptive Procedures Count by Segments and Forecast to 2030
Spain Reversible Contraceptive Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “Spain Reversible Contraceptive Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Spain Reversible Contraceptive Procedures. The databook report pro ... Read More
-
China Reversible Contraceptive Procedures Count by Segments and Forecast to 2030
China Reversible Contraceptive Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “China Reversible Contraceptive Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the China Reversible Contraceptive Procedures. The databook report pro ... Read More
-
Brazil Reversible Contraceptive Procedures Count by Segments and Forecast to 2030
Brazil Reversible Contraceptive Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “Brazil Reversible Contraceptive Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Brazil Reversible Contraceptive Procedures. The databook report ... Read More
-
India Neurology Procedures Count by Segments and Forecast to 2030
India Neurology Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “India Neurology Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the India Neurology Procedures. The databook report provides procedure volumes within segments - Dur ... Read More
Research Assistance
